Faculty
Hoss A Dowlat, PhD
Vice President, Regulatory Affairs EU-USA, Global Strategy, PharmaBio Consulting (Life Sciences), Germany
EU/US/Japan Regulatory submissions, Scientific Advice, NDA/BLA//MAA or IND/CTA. Biologics, Orphan Drugs. Biosimilars. Pharm dev, clinical research and medicinal safety including EU PIPs and RMPs, and US/EU PI.
Weining HU
VP of Global Regulatory Affairs, Gan & Lee Pharmaceuticals, China
Joe Zhang
Co-founder and CEO, BJ Bioscience Inc., China
Carol Zhu, MBA
Vice President, Portfolio and Project Management, JW Therapeutics, China
Carol Zhu, RPh, MBA, serves as Senior Vice President and Managing Director for DIA Greater China. She joined DIA from the Bill & Melinda Gates Foundation, where she was the Senior Program Officer for R&D Programs. Prior to her work at the Gates Foundation, she was Founder and Chief Executive Officer of START Shanghai, one of the first phase 1 oncology service companies in China. She also held positions at Merck Sharp & Dohme and GlaxoSmithKline, where she was key to establishing GSK’s R&D Center in Shanghai. Ms. Zhu earned her Masters Degree in Business Administration from Rutgers University and her undergraduate degree in pharmaceutical science from Peking University Health Science Center (Beijing Medical University).
Have an account?